Is Dexamethasone Helpful in Reducing Perihematoma Edema and for the Outcome of Intracerebral Hemorrhage?
Journal of Clinical Medicine · 02.01.2026 · 15 (1) · 352
DOI: 10.3390/jcm15010352 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Clinical Medicine, online erschienen am 02.01.2026. Verfasst von Jayantee Kalita und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Sanjay Gandhi Post Graduate Institute of Medical Sciences, Raebareli Road, Lucknow 226014, Uttar Pradesh, India. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
In primary supratentorial intracerebral hemorrhage (PSICH), dexamethasone (Dexa) may be effective in reducing perihematoma edema (PHE). We compare the changes in the PHE, hematoma edema complex (HEC), and midline shift (MLS) in patients with PSICH in the Dexa and Non-Dexa groups.
Methods
The CT-proven PSICHs were included, and their stroke risk factors, Glasgow Coma Scale (GCS) score, and National Institute of Health Stroke Scale (NIHSS) score were noted. Thirty-one patients received intravenous dexamethasone from day 4 to day 7 of stroke in a dose of 24 mg, 12 mg, and 8 mg daily for 3 days each. Thirty-three patients did not receive dexamethasone. The primary outcome was the change in PHE, HEC, and MLS at 15 days compared to the pre-Dexa CT scan, and the secondary outcomes were death and disability at 3 months and side effects.
Results
The Dexa group had a higher volume of ICH, HEC, and PHE, and MLS compared to the Non-Dexa group, although their age, NIHSS and GCS scores were comparable at admission and just before intervention. The Dexa group had a larger reduction in HEC (p = 0.03) and MLS (p < 0.01) compared to the Non-Dexa group. The change in PHE volume was also insignificantly higher in the Dexa group (p = 0.36). At 3 months, the patients with medium (p < 0.001) and large-size hematomas (p < 0.001) in the Dexa group had a good outcome, but this benefit was not observed in small hematomas.
Conclusions
In PSICH, dexamethasone after 3 days reduces the HEC and MLS and may have survival and disability benefits especially in medium and large hematomas. A multicentric–randomized–controlled trial may confirm these findings.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Neurology, Sanjay Gandhi Post Graduate Institute of Medical Sciences, Raebareli Road, Lucknow 226014, Uttar Pradesh, India.
- Department of Radiodiagnosis, Sanjay Gandhi Post Graduate Institute of Medical Sciences, Raebareli Road, Lucknow 226014, Uttar Pradesh, India.
ORCID-Profile: Sandeep Kumar Gupta, Prakash C Pandey, Roopali Mahajan
Zitieren
APA
Kalita, J., Gupta, S. K., Kumar, D., Nizami, F. M., Pandey, P. C., Mahajan, R., & Singh, V. (2026). Is Dexamethasone Helpful in Reducing Perihematoma Edema and for the Outcome of Intracerebral Hemorrhage?. Journal of Clinical Medicine, 15(1), 352. https://doi.org/10.3390/jcm15010352
Vancouver
Kalita J, Gupta SK, Kumar D, Nizami FM, Pandey PC, Mahajan R, et al. Is Dexamethasone Helpful in Reducing Perihematoma Edema and for the Outcome of Intracerebral Hemorrhage?. Journal of Clinical Medicine. 2026;15(1):352. doi:10.3390/jcm15010352
BibTeX
@article{Kalita2026,
author = {Kalita, Jayantee and Gupta, Sandeep Kumar and Kumar, Dhiraj and Nizami, Firoz M and Pandey, Prakash C and Mahajan, Roopali and Singh, Vivek},
title = {Is Dexamethasone Helpful in Reducing Perihematoma Edema and for the Outcome of Intracerebral Hemorrhage?},
journal = {Journal of Clinical Medicine},
year = {2026},
volume = {15},
number = {1},
pages = {352},
doi = {10.3390/jcm15010352}
}
EUVIMED